<ARTICLE> 5 <MULTIPLIER> 1,000 <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> DEC-31-1997 <PERIOD-END> MAR-31-1997 <CASH> 1,042,119 <SECURITIES> 75,361 <RECEIVABLES> 1,620,415 <ALLOWANCES> 66,336 <INVENTORY> 876,264 <CURRENT-ASSETS> 4,275,747 <PP&E> 7,002,555 <DEPRECIATION> 2,808,226 <TOTAL-ASSETS> 14,513,618 <CURRENT-LIABILITIES> 4,061,749 <BONDS> 2,509,649 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 355,564 <OTHER-SE> 6,213,909 <TOTAL-LIABILITY-AND-EQUITY> 14,513,618 <SALES> 1,833,779 <TOTAL-REVENUES> 1,953,000 <CGS> 449,151 <TOTAL-COSTS> 541,345 <OTHER-EXPENSES> 772,856<F1> <LOSS-PROVISION> 0<F2> <INTEREST-EXPENSE> 60,631 <INCOME-PRETAX> 576,829 <INCOME-TAX> 144,213 <INCOME-CONTINUING> 432,616 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 432,616 <EPS-PRIMARY> .76 <EPS-DILUTED> .76 <FN> <F1>Amounts include research and development, marketing and administrative expenses. <F2>The information called for is not given as the balances are not individually significant. </FN>